1
/
of
1
Elabscience
SKU:PKSV030470
Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron)
Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron), a cutting-edge product meticulously engineered to cater to the evolving demands of the scientific community. This protein, derived from the novel Omicron variant, showcases an exceptional level of quality and reliability, making it an indispensable tool for various research applications.
Crafted through advanced recombinant technology, this Nucleocapsid Protein (N-His Tag)(Omicron) exhibits a high degree of purity, ensuring accurate and reproducible results in experimental settings. Its N-terminal Histidine (His) tag facilitates efficient purification and subsequent downstream applications, enabling researchers to delve deeper into the intricate mechanisms of the SARS-CoV-2 virus.
With its unrivaled specificity, this recombinant protein serves as an invaluable resource for studying the Omicron variant's nucleocapsid protein, a pivotal component in viral replication and pathogenesis. By employing this product, researchers can unravel the intricate interplay between the virus and host cells, shedding light on potential therapeutic targets and aiding in the development of effective countermeasures.
The Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron) adheres to stringent quality control measures, ensuring its integrity and consistency. Each batch undergoes rigorous testing to guarantee its purity, functionality, and absence of contaminants, thereby instilling confidence in its suitability for a wide range of applications, including but not limited to protein-protein interaction studies, diagnostic assay development, and vaccine research.
Furthermore, this product is accompanied by comprehensive technical documentation, providing researchers with detailed protocols, storage guidelines, and recommended experimental conditions. Such meticulous attention to detail empowers scientists to optimize their experimental design and maximize the utility of this recombinant protein, ultimately accelerating scientific progress in the battle against the SARS-CoV-2 virus.
In summary, the Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron) represents a pinnacle of scientific innovation, offering researchers an indispensable tool to unravel the intricacies of the Omicron variant. Its exceptional purity, specificity, and reliability make it an invaluable asset in various research endeavors, propelling advancements in our understanding of viral pathogenesis and aiding in the development of effective therapeutic interventions.
Crafted through advanced recombinant technology, this Nucleocapsid Protein (N-His Tag)(Omicron) exhibits a high degree of purity, ensuring accurate and reproducible results in experimental settings. Its N-terminal Histidine (His) tag facilitates efficient purification and subsequent downstream applications, enabling researchers to delve deeper into the intricate mechanisms of the SARS-CoV-2 virus.
With its unrivaled specificity, this recombinant protein serves as an invaluable resource for studying the Omicron variant's nucleocapsid protein, a pivotal component in viral replication and pathogenesis. By employing this product, researchers can unravel the intricate interplay between the virus and host cells, shedding light on potential therapeutic targets and aiding in the development of effective countermeasures.
The Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron) adheres to stringent quality control measures, ensuring its integrity and consistency. Each batch undergoes rigorous testing to guarantee its purity, functionality, and absence of contaminants, thereby instilling confidence in its suitability for a wide range of applications, including but not limited to protein-protein interaction studies, diagnostic assay development, and vaccine research.
Furthermore, this product is accompanied by comprehensive technical documentation, providing researchers with detailed protocols, storage guidelines, and recommended experimental conditions. Such meticulous attention to detail empowers scientists to optimize their experimental design and maximize the utility of this recombinant protein, ultimately accelerating scientific progress in the battle against the SARS-CoV-2 virus.
In summary, the Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His Tag)(Omicron) represents a pinnacle of scientific innovation, offering researchers an indispensable tool to unravel the intricacies of the Omicron variant. Its exceptional purity, specificity, and reliability make it an invaluable asset in various research endeavors, propelling advancements in our understanding of viral pathogenesis and aiding in the development of effective therapeutic interventions.
Share
